转移性割抗性前列腺癌:关于当前治疗和有前途的实验药物的见解
Simone Ferretti1, Chiara Mercinelli2, Laura Marandino2
1Department of Medical, Oral and Biotechnological Sciences, G. d'Annunzio University of Chieti, Urology Unit, Chieti, Italy.
Research and reports in urology
|July 3, 2023
概括
转移性割抵抗性前列腺癌 (mCRPC) 的治疗正在随着新疗法,如卢塞-177 PSMA-617 和 PARP 抑制剂的发展而发展. 目前正在进行研究,以寻找针对个性化mCRPC治疗策略的预测生物标志物.
科学领域:
- 在瘤学瘤学.
- 医学物理 医学物理
背景情况:
- 转移性割抵抗性前列腺癌 (mCRPC) 的治疗环境正在迅速发展.
- 已建立的疗法包括化疗,雄激素受体轴向疗法 (ARAT) 和-223.
研究的目的:
- 审查目前和新兴的mCRPC治疗策略.
- 突出治疗诊断和向治疗的进展.
- 讨论生物标志物在个性化mCRPC治疗中的作用.
主要方法:
- 对mCRPC当前治疗选择的文献综述.
- 分析新的治疗策略,包括治疗术和新药.
- 在mCRPC中讨论生物标志物研究.
主要成果:
- -177 (177Lu) -PSMA-617是PSMA阳性的mCRPC的新标准.
- 像Olaparib这样的Poly-ADP-ribose聚合酶 (PARP) 抑制剂在精选的mCRPC患者中显示出有效性.
- 免疫疗法在未经选择的mCRPC群体中显示出有限的疗效,需要进一步研究.
结论:
- 对于mCRPC来说,正在出现新的护理标准,包括诊断和向治疗.
- 预测生物标志物对于在mCRPC中开发定制的治疗策略至关重要.
- 对于mCRPC,进一步探索新的免疫疗法方法是有必要的.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


